0001816590-24-000059.txt : 20240401
0001816590-24-000059.hdr.sgml : 20240401
20240401085559
ACCESSION NUMBER: 0001816590-24-000059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240328
FILED AS OF DATE: 20240401
DATE AS OF CHANGE: 20240401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Malievskaia Ekaterina
CENTRAL INDEX KEY: 0001898326
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39522
FILM NUMBER: 24805787
MAIL ADDRESS:
STREET 1: C/O COMPASS PATHWAYS PLC, 3RD FLOOR
STREET 2: 1 ASHLEY ROAD, ALTRINCHAM
CITY: CHESHIRE
STATE: X0
ZIP: WA14 2DT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COMPASS Pathways plc
CENTRAL INDEX KEY: 0001816590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3RD FLOOR, 1 ASHLEY ROAD
STREET 2: ALTRINCHAM
CITY: CHESIRE
STATE: X0
ZIP: WA14 2DT
BUSINESS PHONE: 1-716-676-6461
MAIL ADDRESS:
STREET 1: 3RD FLOOR, 1 ASHLEY ROAD
STREET 2: ALTRINCHAM
CITY: CHESIRE
STATE: X0
ZIP: WA14 2DT
FORMER COMPANY:
FORMER CONFORMED NAME: Compass Rx Ltd.
DATE OF NAME CHANGE: 20200701
4
1
wk-form4_1711976149.xml
FORM 4
X0508
4
2024-03-28
0
0001816590
COMPASS Pathways plc
CMPS
0001898326
Malievskaia Ekaterina
COMPASS PATHWAYS PLC
33 BROADWICK STREET
LONDON
X0
W1F 0DQ
UNITED KINGDOM
0
0
1
0
1
Ordinary Shares
2024-03-28
4
S
0
25750
8.6515
D
4033880
D
Ordinary Shares
2024-03-28
4
S
0
25750
8.6515
D
4036154
I
By: Spouse
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Dr. Malievskaia on August 23, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.31 to $9.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Goldsmith on August 23, 2023.
Securities held by George Jay Goldsmith, the Reporting Person's spouse. Dr. Malievskaia and Mr. Goldsmith are married but they expressly disclaim beneficial ownership of each other's shares in the Issuer.
/s/ Meredith Prithviraj by Power of Attorney for Ekaterina Malievskaia
2024-04-01